Reduced serum VGF levels were reversed by antidepressant treatment in depressed patients

References

• Alder J, Thakker-Varia S, Bangasser DA, Kuroiwa M, Plummer MR, Shors TJ, Black IB. 2003. Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity. J Neurosci. 23:10800–10808.
   Google Scholar
• Allaman I, Fiumelli H, Magistretti PJ, Martin JL. 2011. Fluoxetine regulates the expression of neurotrophic/growth factors and glucose metabolism in astrocytes. Psychopharmacology (Berl). 216:75–84.
   Google Scholar
• Altar CA, Laeng P, Jurata LW, Brockman JA, Lemire A, Bullard J, Bukhman Y, Young TA, Charles V, Palfreyman MG. 2004. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J Neurosci. 24:2667–2677.
   Google Scholar
• Ballas C, Staab JP, Evans DL. 2002. Strategies for treatment-resistant depression. Psychopharmacol Bull. 36:39–62.
   Google Scholar
• Bonni A, Ginty DD, Dudek H, Greenberg ME. 1995. Serine 133-phosphorylated CREB induces transcription via a cooperative mechanism that may confer specificity to neurotrophin signals. Mol Cell Neurosci. 6:168–183.
   Google Scholar
• Bozdagi O, Rich E, Tronel S, Sadahiro M, Patterson K, Shapiro ML, Alberini CM, Huntley GW, Salton SR. 2008. The neurotrophin-inducible gene Vgf regulates hippocampal function and behavior through a brain-derived neurotrophic factor-dependent mechanism. J Neurosci. 28:9857–9869.
   Google Scholar
• Busse S, Bernstein HG, Busse M, Bielau H, Brisch R, Mawrin C, Müller S, Sarnyai Z, Gos T, Bogerts B, Steiner J. 2012. Reduced density of hypothalamic VGF-immunoreactive neurons in schizophrenia: a potential link to impaired growth factor signaling and energy homeostasis. Eur Arch Psychiatry Clin Neurosci. 262:365–374.
   Google Scholar
• Cattaneo A, Bocchio-Chiavetto L, Zanardini R, Milanesi E, Placentino A, Gennarelli M. 2010a. Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalised by antidepressant treatment. Int J Neuropsychopharmacol. 13:103–108.
   Google Scholar
• Cattaneo A, Gennarelli M, Uher R, Breen G, Farmer A, Aitchison KJ, Craig IW, Anacker C, Zunsztain PA, McGuffin P, Pariante CM. 2013. Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'. Neuropsychopharmacology. 38:377–385.
   Google Scholar
• Cattaneo A, Sesta A, Calabrese F, Nielsen G, Riva MA, Gennarelli M. 2010b. The expression of VGF is reduced in leukocytes of depressed patients and it is restored by effective antidepressant treatment. Neuropsychopharmacology. 35:1423–1428.
   Google Scholar
• Conti B, Maier R, Barr AM, Morale MC, Lu X, Sanna PP, Bilbe G, Hoyer D, Bartfai T. 2007. Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine. Mol Psychiatry. 12:167–189.
   Google Scholar
• de Kloet ER, Molendijk ML. 2016. Coping with the forced swim stressor: towards understanding an adaptive mechanism. Neural Plast. 2016:6503162.
   Google Scholar
• Duric V, Duman RS. 2013. Depression and treatment response: dynamic interplay of signaling pathways and altered neural processes. Cell Mol Life Sci. 70:39–53.
   Google Scholar
• Hamilton M. 1960. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:56–62.
   Google Scholar
• Hunsberger JG, Newton SS, Bennett AH, Duman CH, Russell DS, Salton SR, Duman RS. 2007. Antidepressant actions of the exercise-regulated gene VGF. Nat Med. 13:1476–1482.
   Google Scholar
• Lecube A, Poca MA, Colome N, Bech-Serra JJ, Hernandez C, Garcia-Ramirez M, Gándara D, Canals F, Simó R. 2012. Proteomic analysis of cerebrospinal fluid from obese women with idiopathic intracranial hypertension: a new approach for identifying new candidates in the pathogenesis of obesity. J Neuroendocrinol. 24:944–952.
   Google Scholar
• Levi A, Eldridge JD, Paterson BM. 1985. Molecular cloning of a gene sequence regulated by nerve growth factor. Science. 229:393–395.
   Google Scholar
• Lewis JE, Brameld JM, Jethwa PH. 2015. Neuroendocrine Role for VGF. Front Endocrinol (Lausanne). 6:3.
   Google Scholar
• Lin P, Wang C, Xu B, Gao S, Guo J, Zhao X, Huang H, Zhang J, Chen X, Wang Q, Zhou W. 2014. The VGF-derived peptide TLQP62 produces antidepressant-like effects in mice via the BDNF/TrkB/CREB signaling pathway. Pharmacol Biochem Behav. 120:140–148.
   Google Scholar
• Malberg JE, Monteggia LM. 2008. VGF, a new player in antidepressant action? Sci Signal. 1:pe19.
   Google Scholar
• Molendijk ML, de Kloet ER. 2015. Immobility in the forced swim test is adaptive and does not reflect depression. Psychoneuroendocrinology. 62:389–391.
   Google Scholar
• Newton SS, Collier EF, Hunsberger J, Adams D, Terwilliger R, Selvanayagam E, Duman RS. 2003. Gene profile of electroconvulsive seizures: induction of neurotrophic and angiogenic factors. J Neurosci. 23:10841–10851.
   Google Scholar
• Rasmusson AM, Shi L, Duman R. 2002. Downregulation of BDNF mRNA in the hippocampal dentate gyrus after re-exposure to cues previously associated with footshock. Neuropsychopharmacology. 27:133–142.
   Google Scholar
• Salton SR, Fischberg DJ, Dong KW. 1991. Structure of the gene encoding VGF, a nervous system-specific mRNA that is rapidly and selectively induced by nerve growth factor in PC12 cells. Mol Cell Biol. 11:2335–2349.
   Google Scholar
• Stein S, Winnik S, Matter CM. 2015. Brain-derived neurotrophic factor Val66Met polymorphism in depression and thrombosis: SIRT1 as a possible mediator. Eur Heart J. pii:ehv692.
   Google Scholar
• Tanis KQ, Newton SS, Duman RS. 2007. Targeting neurotrophic/growth factor expression and signaling for antidepressant drug development. CNS Neurol Disord Drug Targets. 6:151–160.
   Google Scholar
• Thakker-Varia S, Alder J. 2009. Neuropeptides in depression: role of VGF. Behav Brain Res. 197:262–278.
   Google Scholar
• Thakker-Varia S, Jean YY, Parikh P, Sizer CF, Jernstedt Ayer J, Parikh A, Hyde TM, Buyske S, Alder J. 2010. The neuropeptide VGF is reduced in human bipolar postmortem brain and contributes to some of the behavioral and molecular effects of lithiummortem. J Neurosci. 30:9368–9380.
   Google Scholar
• Thakker-Varia S, Krol JJ, Nettleton J, Bilimoria PM, Bangasser DA, Shors TJ, Black IB, Alder J. 2007. The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus. J Neurosci. 27:12156–12167.
   Google Scholar
• Willner P, Scheel-Kruger J, Belzung C. 2013. The neurobiology of depression and antidepressant action. Neurosci Biobehav Rev. 37:2331–2371.
   Google Scholar